The myeloid cytokine network in AIDS pathogenesis

Cytokine and Growth Factor Reviews

Volumn 23, Issue 4-5, 2012, Pages 223-231

  Mir, Kiran D ^a   Mavigner, Maud ^a   Silvestri, Guido ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; Macrophages; Monocytes; SIV

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MONOCYTE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CYTOKINES; DENDRITIC CELLS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MODELS, IMMUNOLOGICAL; MONOCYTES; MYELOID CELLS;

SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84864947011     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2012.05.009     Document Type: Short Survey

References (136)

1. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology 2011, 11:723-737.
2. Belz G.T., Nutt S.L. Transcriptional programming of the dendritic cell network. Nature Reviews Immunology 2012, 12:101-113.
3. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. The Journal of Immunology 2005, 175:342-349.
4. Brown C.R., Czapiga M., Kabat J., Dang Q., Ourmanov I., Nishimura Y., et al. Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS. Journal of Virology 2007, 81:5594-5606.
5. Ortiz A.M., Klatt N.R., Li B., Yi Y., Tabb B., Hao X.P., et al. Depletion of CD4 T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques. Journal of Clinical Investigation 2011, 121:4433-4445.
6. Burdo T.H., Soulas C., Orzechowski K., Button J., Krishnan A., Sugimoto C., et al. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathogens 2010, 6:e1000842.
7. Heggelund L., Müller F., Lien E., Yndestad A., Ueland T., Kristiansen K.I., et al. Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clinical Infectious Diseases 2004, 39:264-269.
8. Swingler S., Mann A., Jacque J.M., Brichacek B., Sasseville V.G., Williams K., et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nature Medicine 1999, 5:997-1003.
9. van't Wout A.B., Kootstra N.A., Mulder-Kampinga G.A., Albrecht-van Lent N., Scherpbier H.J., Veenstra J., et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. Journal of Clinical Investigation 1994, 94:2060-2067.
10. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993, 261:1179-1181.
11. Salazar-Gonzalez J.F., Salazar M.G., Keele B.F., Learn G.H., Giorgi E.E., Li H., et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. Journal of Experimental Medicine 2009, 206:1273-1289.
12. Li Q., Duan L., Estes J.D., Ma Z.M., Rourke T., Wang Y., et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005, 434:1148-1152.
13. Schacker T., Little S., Connick E., Gebhard K., Zhang Z.Q., Krieger J., et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. Journal of Infectious Diseases 2001, 183:555-562.
14. Zhang Z., Schuler T., Zupancic M., Wietgrefe S., Staskus K.A., Reimann K.A., et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999, 286:1353-1357.
15. Haase A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464:217-223.
16. Miller C.J., Hu J. T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV. Journal of Infectious Diseases 1999, 179(Suppl 3):S413-S417.
17. Spira A.I., Marx P.A., Patterson B.K., Mahoney J., Koup R.A., Wolinsky S.M., et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. Journal of Experimental Medicine 1996, 183:215-225.
18. Stahl-Hennig C., Steinman R.M., Tenner-Racz K., Pope M., Stolte N., Matz-Rensing K., et al. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 1999, 285:1261-1265.
19. Kwon D.S., Gregorio G., Bitton N., Hendrickson W.A., Littman D.R. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 2002, 16:135-144.
20. Garcia E., Pion M., Pelchen-Matthews A., Collinson L., Arrighi J.F., Blot G., et al. HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 2005, 6:488-501.
21. Izquierdo-Useros N., Blanco J., Erkizia I., Fernandez-Figueras M.T., Borras F.E., Naranjo-Gomez M., et al. Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission. Journal of Virology 2007, 81:7559-7570.
22. Dong C., Deng F., Li D., Wang H., Hu Z. The heptad repeats region is essential for AcMNPV P10 filament formation and not the proline-rich or the C-terminus basic regions. Virology 2007, 365:390-397.
23. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
24. Gurney K.B., Elliott J., Nassanian H., Song C., Soilleux E., McGowan I., et al. Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa. Journal of Virology 2005, 79:5762-5773.
25. Wilkinson J., Cunningham A.L. Mucosal transmission of HIV-1: first stop dendritic cells. Current Drug Targets 2006, 7:1563-1569.
26. Wu L., KewalRamani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nature Reviews Immunology 2006, 6:859-868.
27. Gartner S., Markovits P., Markovitz D.M., Kaplan M.H., Gallo R.C., Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986, 233:215-219.
28. Sharova N., Swingler C., Sharkey M., Stevenson M. Macrophages archive HIV-1 virions for dissemination in trans. EMBO Journal 2005, 24:2481-2489.
29. Ho D.D., Rota T.R., Hirsch M.S. Infection of monocyte/macrophages by human T lymphotropic virus type III. Journal of Clinical Investigation 1986, 77:1712-1715.
30. Nicholson J.K., Cross G.D., Callaway C.S., McDougal J.S. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). Journal of Immunology 1986, 137:323-329.
31. Deneka M., Pelchen-Matthews A., Byland R., Ruiz-Mateos E., Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. The Journal of Cell Biology 2007, 177:329-341.
32. Carter G.C., Bernstone L., Sangani D., Bee J.W., Harder T., James W. HIV entry in macrophages is dependent on intact lipid rafts. Virology 2009, 386:192-202.
33. Gousset K., Ablan S.D., Coren L.V., Ono A., Soheilian F., Nagashima K., et al. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathogens 2008, 4:e1000015.
34. Groot F., Welsch S., Sattentau Q.J. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 2008, 111:4660-4663.
35. Gras G., Kaul M. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 2010, 7:30.
36. Qin D., Wu J., Burton G.F., Szakal A.K., Tew J.G. A role for CR2 in FDC-B cell interactions. Advances in Experimental Medicine and Biology 1997, 417:493-497.
37. Smith B.A., Gartner S., Liu Y., Perelson A.S., Stilianakis N.I., Keele B.F., et al. Persistence of infectious HIV on follicular dendritic cells. Journal of Immunology 2001, 166:690-696.
38. Chougnet C., Cohen S.S., Kawamura T., Landay A.L., Kessler H.A., Thomas E., et al. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. Journal of Immunology 1999, 163:1666-1673.
39. Larsson M. HIV-1 and the hijacking of dendritic cells: a tug of war. Springer Seminars in Immunopathology 2005, 26:309-328.
40. Tsunetsugu-Yokota Y., Akagawa K., Kimoto H., Suzuki K., Iwasaki M., Yasuda S., et al. Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation. Journal of Virology 1995, 69:4544-4547.
41. Bakri Y., Schiffer C., Zennou V., Charneau P., Kahn E., Benjouad A., et al. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. Journal of Immunology 2001, 166:3780-3788.
42. Kedzierska K., Crowe S.M. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Current Medicinal Chemistry 2002, 9:1893-1903.
43. Orenstein J.M., Fox C., Wahl S.M. Macrophages as a source of HIV during opportunistic infections. Science 1997, 276:1857-1861.
44. Zhu T. HIV-1 in peripheral blood monocytes: an underrated viral source. Journal of Antimicrobial Chemotherapy 2002, 50:309-311.
45. Chang J., Naif H.M., Li S., Sullivan J.S., Randle C.M., Cunningham A.L. Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro. Journal of Virology 1996, 70:7792-7803.
46. Bol S.M., van Remmerden Y., Sietzema J.G., Kootstra N.A., Schuitemaker H., van't Wout A.B. Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages. Virology 2009, 390:205-211.
47. Shen R., Richter H.E., Clements R.H., Novak L., Huff K., Bimczok D., et al. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. Journal of Virology 2009, 83:3258-3267.
48. Di Marzio P., Tse J., Landau N.R. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. AIDS Research and Human Retroviruses 1998, 14:129-138.
49. Naif H.M., Li S., Alali M., Sloane A., Wu L., Kelly M., et al. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. Journal of Virology 1998, 72:830-836.
50. Tuttle D.L., Harrison J.K., Anders C., Sleasman J.W., Goodenow M.M. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. Journal of Virology 1998, 72:4962-4969.
51. Sonza S., Maerz A., Deacon N., Meanger J., Mills J., Crowe S. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. Journal of Virology 1996, 70:3863-3869.
52. Triques K., Stevenson M. Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. Journal of Virology 2004, 78:5523-5527.
53. Peng G., Greenwell-Wild T., Nares S., Jin W., Lei K.J., Rangel Z.G., et al. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 2007, 110:393-400.
54. Wang X., Ye L., Hou W., Zhou Y., Wang Y.J., Metzger D.S., et al. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 2009, 113:671-674.
55. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 2005, 435:108-114.
56. Kaushik R., Zhu X., Stranska R., Wu Y., Stevenson M. A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host and Microbe 2009, 6:68-80.
57. Negre D., Mangeot P.E., Duisit G., Blanchard S., Vidalain P.O., Leissner P., et al. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Therapy 2000, 7:1613-1623.
58. Neil S., Martin F., Ikeda Y., Collins M. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. Journal of Virology 2001, 75:5448-5456.
59. Berger A., Sommer A.F., Zwarg J., Hamdorf M., Welzel K., Esly N., et al. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathogens 2011, 7:e1002425.
60. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661.
61. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Segeral E., et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657.
62. Goujon C., Arfi V., Pertel T., Luban J., Lienard J., Rigal D., et al. Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. Journal of Virology 2008, 82:12335-12345.
63. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
64. Sharova N., Wu Y., Zhu X., Stranska R., Kaushik R., Sharkey M., et al. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathogens 2008, 4:e1000057.
65. Fujita M., Otsuka M., Nomaguchi M., Adachi A. Multifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions. Reviews in Medical Virology 2010, 20:68-76.
66. Goujon C., Riviere L., Jarrosson-Wuilleme L., Bernaud J., Rigal D., Darlix J.L., et al. SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology 2007, 4:2.
67. Xu R., Klatt G., Wadepohl H., Koppel H. Hydrogen scrambling in [(C(5)R(5))(L)M(H)(C(2)H(4))](+) (M=Co, Rh). Relation of experimental kinetic data to the barriers of the elementary reaction steps. Inorganic Chemistry 2010, 49:3289-3296.
68. Lim E.S., Fregoso O.I., McCoy C.O., Matsen F.A., Malik H.S., Emerman M. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host and Microbe 2012, 11:194-204.
69. Hirsch V.M., Sharkey M.E., Brown C.R., Brichacek B., Goldstein S., Wakefield J., et al. Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nature Medicine 1998, 4:1401-1408.
70. Berger A., Munk C., Schweizer M., Cichutek K., Schule S., Flory E. Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes. Journal of Biological Chemistry 2010, 285:12248-12254.
71. Goujon C., Jarrosson-Wuilleme L., Bernaud J., Rigal D., Darlix J.L., Cimarelli A. With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). Gene Therapy 2006, 13:991-994.
72. Schule S., Kloke B.P., Kaiser J.K., Heidmeier S., Panitz S., Wolfrum N., et al. Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj. PLoS ONE 2009, 4:e7098.
73. Lahouassa H., Daddacha W., Hofmann H., Ayinde D., Logue E.C., Dragin L., et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nature Immunology 2012, 13:223-228.
74. Hockett R.D., Kilby J.M., Derdeyn C.A., Saag M.S., Sillers M., Squires K., et al. Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. Journal of Experimental Medicine 1999, 189:1545-1554.
75. Igarashi T., Imamichi H., Brown C.R., Hirsch V.M., Martin M.A. The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys. Journal of Leukocyte Biology 2003, 74:772-780.
76. Pantaleo G., Graziosi C., Butini L., Pizzo P.A., Schnittman S.M., Kotler D.P., et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:9838-9842.
77. Igarashi H., Kouro T., Yokota T., Comp P.C., Kincade P.W. Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:15131-15136.
78. Sacha J.B., Giraldo-Vela J.P., Buechler M.B., Martins M.A., Maness N.J., Chung C., et al. Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:9791-9796.
79. Koyama S., Ishii K.J., Coban C., Akira S. Innate immune response to viral infection. Cytokine 2008, 43:336-341.
80. Civas A., Island M.-L., Génin P., Morin P., Navarro S. Regulation of virus-induced interferon-A genes. Biochimie 2002, 84:643-654.
81. Sodora D.L., Silvestri G. Immune activation and AIDS pathogenesis. AIDS 2008, 22:439-446.
82. Meier A., Alter G., Frahm N., Sidhu H., Li B., Bagchi A., et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. Journal of Virology 2007, 81:8180-8191.
83. Francis M., Fan X., Meltzer M. Loss ability to produce IFN-alpha in response to HIV-1 as monocytes differentiate into macrophages. Induction through a mechanism independent of double-stranded RNA. The Journal of Immunology 1996, 156:2481-2487.
84. Han X., Li X., Yue S.C., Anandaiah A., Hashem F., Reinach P.S., et al. Epigenetic regulation of TNFα release in human macrophages by HIV-1 ssRNA is dependent on TLR8. Journal of Biological Chemistry 2012, 287:13778-13786.
85. Schlee M., Hartmann E., Coch C., Wimmenauer V., Janke M., Barchet W., et al. Approaching the RNA ligand for RIG-I?. Immunological Reviews 2009, 227:66-74.
86. Solis M., Nakhaei P., Jalalirad M., Lacoste J., Douville R., Arguello M., et al. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. Journal of Virology 2011, 85:1224-1236.
87. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5[alpha] restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
88. Sheehy A.M., Gaddis N.C., Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nature Medicine 2003, 9:1404-1407.
89. Neil S.J.D., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
90. Tsang J., Chain B.M., Miller R.F., Webb B.L., Barclay W., Towers G.J., et al. HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS 2009, 23:2255-2263. 10.1097/QAD.0b013e328331a4ce.
91. Yan N., Regalado-Magdos A.D., Stiggelbout B., Lee-Kirsch M.A., Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nature Immunology 2010, 11:1005-1013.
92. Trapp S., Derby N.R., Singer R., Shaw A., Williams V.G., Turville S.G., et al. Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. Journal of Virology 2009, 83:884-895.
93. Barber S.A., Herbst D.S., Bullock B.T., Gama L., Clements J.E. Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. Journal of Neurovirology 2004, 1:15-20.
94. Orandle M.S., MacLean A.G., Sasseville V.G., Alvarez X., Lackner A.A. Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis. Journal of Virology 2002, 76:5797-5802.
95. Akhtar L.N., Qin H., Muldowney M.T., Yanagisawa L.L., Kutsch O., Clements J.E., et al. Suppressor of cytokine signaling 3 inhibits antiviral IFN-β signaling to enhance HIV-1 replication in macrophages. The Journal of Immunology 2010, 185:2393-2404.
96. Alammar L., Gama L., Clements J.E. Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection. The Journal of Immunology 2011, 186:4008-4018.
97. Zaritsky L.A., Gama L., Clements J.E. Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2. The Journal of Immunology 2012, 188:3876-3885.
98. Henderson A.J., Zou X., Calame K.L. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. Journal of Virology 1995, 69:5337-5344.
99. Henderson A.J., Connor R.I., Calame K.L. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 1996, 5:91-101.
100. Henderson A.J., Calame K.L. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4+ T cells. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:8714-8719.
101. Ossipow V., Descombes P., Schibler U. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:8219-8223.
102. Welm A.L., Mackey S.L., Timchenko L.T., Darlington G.J., Timchenko N.A. Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein α mRNA. Journal of Biological Chemistry 2000, 275:27406-27413.
103. Dudaronek J.M., Barber S.A., Clements J.E. CUGBP1 is required for IFNbeta-mediated induction of dominant-negative CEBPbeta and suppression of SIV replication in macrophages. Journal of Immunology 2007, 179:7262-7269.
104. Manel N., Hogstad B., Wang Y., Levy D.E., Unutmaz D., Littman D.R. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 2010, 467:214-217.
105. Harman A.N., Lai J., Turville S., Samarajiwa S., Gray L., Marsden V., et al. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood 2011, 118:298-308.
106. Bosinger S.E., Sodora D.L., Silvestri G. Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. Current Opinion in HIV and AIDS 2011, 6:411-418.
107. Mir K.D., Gasper M., Sundaravaradan V., Sodora D.L. SIV infection in natural hosts: resolution of immune activation during the acute-to-chronic transition phase. Microbes and Infection 2010, 13:14-24.
108. Meier A., Bagchi A., Sidhu H.K., Alter G., Suscovich T.J., Kavanagh D.G., et al. Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands. AIDS 2008, 22:655-658.
109. Trabattoni D., Saresella M., Biasin M., Boasso A., Piacentini L., Ferrante P., et al. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 2003, 101:2514-2520.
110. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
111. Velu V., Kannanganat S., Ibegbu C., Chennareddi L., Villinger F., Freeman G.J., et al. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. Journal of Virology 2007, 81:5819-5828.
112. Keir M.E., Butte M.J., Freeman G.J., Sharpe A.H. PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology 2008, 26:677-704.
113. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nature Reviews Immunology 2011, 11:762-774.
114. Tsou C.L., Peters W., Si Y., Slaymaker S., Aslanian A.M., Weisberg S.P., et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. Journal of Clinical Investigation 2007, 117:902-909.
115. Strauss-Ayali D., Conrad S.M., Mosser D.M. Monocyte subpopulations and their differentiation patterns during infection. Journal of Leukocyte Biology 2007, 82:244-252.
116. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
117. Randolph G.J., Sanchez-Schmitz G., Liebman R.M., Schäkel K. The CD16+ (FcγRIII+) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. The Journal of Experimental Medicine 2002, 196:517-527.
118. Lin Y., Gustafson M.P., Bulur P.A., Gastineau D.A., Witzig T.E., Dietz A.B. Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma. Blood 2011, 117:872-881.
119. - subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation. Clinical & Experimental Immunology 2005, 142:461-470.
120. Gama L., Shirk E.N., Russell J.N., Carvalho K.I., Li M., Queen S.E., et al. Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection. Journal of Leukocyte Biology 2012, 91:803-816.
121. Ancuta P., Autissier P., Wurcel A., Zaman T., Stone D., Gabuzda D. CD16+ monocyte-derived macrophages activate resting T cells for HIV infection by producing CCR3 and CCR4 ligands. The Journal of Immunology 2006, 176:5760-5771.
122. Olivetta E., Percario Z., Fiorucci G., Mattia G., Schiavoni I., Dennis C., et al. HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-κB activation. The Journal of Immunology 2003, 170:1716-1727.
123. Varin A., Manna S.K., Quivy V., Decrion A.-Z., Van Lint C., Herbein G., et al. Exogenous Nef protein activates NF-κB, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Journal of Biological Chemistry 2003, 278:2219-2227.
124. Del Corno M., Liu Q.-H., Schols D., de Clercq E., Gessani S., Freedman B.D., et al. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. Blood 2001, 98:2909-2916.
125. Fantuzzi L., Canini I., Belardelli F., Gessani S. HIV-1 gp120 stimulates the production of β-chemokines in human peripheral blood monocytes through a CD4-independent mechanism. The Journal of Immunology 2001, 166:5381-5387.
126. Choe W., Volsky D.J., Potash M.J. Induction of rapid and extensive β-chemokine synthesis in macrophages by human immunodeficiency virus Type 1 and gp120, independently of their coreceptor phenotype. Journal of Virology 2001, 75:10738-10745.
127. Fantuzzi L., Spadaro F., Vallanti G., Canini I., Ramoni C., Vicenzi E., et al. Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages. Blood 2003, 102:2334-2337.
128. Arenzana-Seisdedos F., Fernandez B., Dominguez I., Jacqué J.M., Thomas D., Diaz-Meco M.T., et al. Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes. Journal of Virology 1993, 67:6596-6604.
129. Herbein G., Gras G., Khan K.A., Abbas W. Macrophage signaling in HIV-1 infection. Retrovirology 2010, 7:34.
130. Estes J.D., Harris L.D., Klatt N.R., Tabb B., Pittaluga S., Paiardini M., et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathogens 2010, 6.
131. Hasegawa A., Liu H., Ling B., Borda J.T., Alvarez X., Sugimoto C., et al. The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 2009, 114:2917-2925.
132. Almeida M., Cordero M., Almeida J., Orfao A. Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection. AIDS 2005, 19:261-271.
133. Donaghy H., Pozniak A., Gazzard B., Qazi N., Gilmour J., Gotch F., et al. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001, 98:2574-2576.
134. Pacanowski J., Kahi S., Baillet M., Lebon P., Deveau C., Goujard C., et al. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 2001, 98:3016-3021.
135. Lore K., Sonnerborg A., Brostrom C., Goh L.E., Perrin L., McDade H., et al. Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 2002, 16:683-692.
136. Wijewardana V., Soloff A.C., Liu X., Brown K.N., Barratt-Boyes S.M. Early myeloid dendritic cell dysregulation is predictive of disease progression in simian immunodeficiency virus infection. PLoS Pathogens 2010, 6:e1001235.